Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial.

Bhandari N, Sharma P, Glass RI, Ray P, Greenberg H, Taneja S, Saksena M, Rao CD, Gentsch JR, Parashar U, Maldonado Y, Ward RL, Bhan MK.

Vaccine. 2006 Jul 26;24(31-32):5817-23. Epub 2006 May 12.

PMID:
16735085
2.

Rotavirus and severe childhood diarrhea.

Parashar UD, Gibson CJ, Bresee JS, Glass RI.

Emerg Infect Dis. 2006 Feb;12(2):304-6.

3.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team.

N Engl J Med. 2006 Jan 5;354(1):23-33.

4.

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group.

N Engl J Med. 2006 Jan 5;354(1):11-22.

5.

Development of candidate rotavirus vaccines derived from neonatal strains in India.

Glass RI, Bhan MK, Ray P, Bahl R, Parashar UD, Greenberg H, Rao CD, Bhandari N, Maldonado Y, Ward RL, Bernstein DI, Gentsch JR.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S30-5. Review.

PMID:
16088802
6.

Rotavirus genotyping: keeping up with an evolving population of human rotaviruses.

Iturriza-Gómara M, Kang G, Gray J.

J Clin Virol. 2004 Dec;31(4):259-65.

PMID:
15494266
7.

Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India.

Iturriza Gómara M, Kang G, Mammen A, Jana AK, Abraham M, Desselberger U, Brown D, Gray J.

J Clin Microbiol. 2004 Jun;42(6):2541-7.

8.

Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988-1999.

Vethanayagam RR, Ananda Babu M, Nagalaxmi KS, Maiya PP, Venkatesh HA, Purohit S, Behl R, Bhan MK, Ward RL, Greenberg HB, Durga Rao C.

J Infect Dis. 2004 Jun 15;189(12):2282-9. Epub 2004 May 25.

PMID:
15181576
9.

Quantitation of group A rotavirus by real-time reverse-transcription-polymerase chain reaction: correlation with clinical severity in children in South India.

Kang G, Iturriza-Gomara M, Wheeler JG, Crystal P, Monica B, Ramani S, Primrose B, Moses PD, Gallimore CI, Brown DW, Gray J.

J Med Virol. 2004 May;73(1):118-22.

10.

Intussusception among infants given an oral rotavirus vaccine.

Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livengood JR; Rotavirus Intussusception Investigation Team.

N Engl J Med. 2001 Feb 22;344(8):564-72. Erratum in: N Engl J Med 2001 May 17;344(20):1564. Livingood, JR [corrected to Livengood, JR].

11.

Comparison of specific and random priming in the reverse transcriptase polymerase chain reaction for genotyping group A rotaviruses.

Iturriza-Gomara M, Green J, Brown DW, Desselberger U, Gray JJ.

J Virol Methods. 1999 Mar;78(1-2):93-103.

PMID:
10204700
12.

Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.

Ramachandran M, Vij A, Kumar R, Das BK, Gentsch JR, Bhan MK, Glass RI.

Clin Diagn Lab Immunol. 1998 Jul;5(4):527-30.

13.

Rotavirus infection in infants as protection against subsequent infections.

Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM.

N Engl J Med. 1996 Oct 3;335(14):1022-8.

14.

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea.

Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI.

J Infect Dis. 1993 Aug;168(2):282-7.

PMID:
8393054
16.

High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus.

Cicirello HG, Das BK, Gupta A, Bhan MK, Gentsch JR, Kumar R, Glass RI.

Pediatr Infect Dis J. 1994 Aug;13(8):720-4.

PMID:
7970972
17.

Diarrhoea--defining the episode.

Morris SS, Cousens SN, Lanata CF, Kirkwood BR.

Int J Epidemiol. 1994 Jun;23(3):617-23.

PMID:
7960391
18.

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

Bishop RF, Barnes GL, Cipriani E, Lund JS.

N Engl J Med. 1983 Jul 14;309(2):72-6.

PMID:
6304516
19.
20.

Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.

Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY.

J Clin Microbiol. 1990 Feb;28(2):276-82.

Supplemental Content

Support Center